FDA Defends Approval of Zohydro, Criticizes Focus on the Drug

After a coalition of more than 70 advocacy groups called for the resignation of the Food and Drug Administration’s commissioner, the administration has published an article in a prominent medical journal defending its approval of the potent, extended-release opioid Zohydro ER. On Sept. 28, the Fed Up Coalition marched in Washington, D.C., to demand the resignation of Commissioner Margaret Hamburg. On Thursday, representatives of the FDA published an article in the Journal of the American Medical Association, calling the decision to approve the drug in October 2013 &l...